期刊文献+

进展性脑梗死患者超敏C反应蛋白和脂蛋白a测定的临床研究 被引量:3

Clinical Study on High-sensitivity C-reactive Protein and Lipoprotein(a) tests in Patients of Progressive Cerebral Infarction
下载PDF
导出
摘要 目的 探讨进展性脑梗死患者血清超敏C反应蛋白(hs-CRP)和脂蛋白a[Lp(a)]测定的临床价值.方法 检测31例进展性脑梗死患者(进展组)和35例非进展性脑梗死患者(非进展组)血请hs-CRP和Lp(a)水平,并与40名健康体检者(对照组)作对照.结果 进展组hs-CRP水平(11.33±2.76 mg/L)显著高于非进展组(6.35±2.15 mg/L)和健康对照组(1.28±0.92 mg/L)(P<0.01);进展组Lp(a)水平(485.63±186.80 mg/L)显著高于非进展组(311.75±28.51 mg/L)和健康对照组(106.87±63.41 mg/L)(P<0.01).结论 血清hs-CRP和Lp(a)联合检测对进展性脑梗死的诊断、病情严重程度、预后具有重要参考价值. Objective To study the clinical value of testing serum high-sensitivity C-reactive protein (hs-CRP) and lipoprotein(a)[Lp(a)] in patients of progressive cerebral infarction. Methods The author tested serum hs-CRP and Lp (a) levels in 31 cases'of progressive cerebral infarction patients(progression team) and 35 cases of non-progressive cerebral infarction patients (non-progression team) ,against the medial check-up results of a group of 40 healthy persons (control team). Results Hs-CRP levels of the progression team (11.33±2.76 mg/L) were significantly higher than those of the non-progression team(6.35±2.15 rag/L) and the control team(1.28±0. 92 rag/L)(P〈0.01);Lp(a) levels of the progression team (485.63± 186.80 rag/L) were significantly higher than those of the non-progression team (311.75/=28.51 mg/L)(P 〈0. 01) and the control team(10G 87±63.41 mg/L)(P〈0. 01). Conclusion Combined testing of hs-CRP and Lp(a) is of high value to the diagnosis and prognosis of progressive cerebral infarction patients.
出处 《现代检验医学杂志》 CAS 2010年第4期118-120,共3页 Journal of Modern Laboratory Medicine
关键词 进展性脑梗死 非进展性脑梗死 超敏C反应蛋白 脂蛋白A progressive cerebral infarction non-progressive cerebral infarction high-sensitivity C-reactive protein lipopro- tein(a)
  • 相关文献

参考文献9

  • 1Emsley HC,Tyrrell PJ.Inflammation and infection in clinical stroke[J].J Cereb Blood Flow Metab,2002,22(12):1399-1419.
  • 2Winbeck K,Poppert H,Etgen T,et al.Prognostic relevance of early serial C-reactive protein measurements after ischemic stroke[J].Stroke,2002,33(10):2459-2464.
  • 3Jurgens G,Koltringer P.Lipoprotein(a) in ischemic cerebrovascular disease:A newapproach to the assessment of risk for stroke[J].Neurology,1987,37(3):513-515.
  • 4王维治.神经病学[M].5版.北京:人民卫生出版社,2004:245
  • 5Muri KW,Weri CJ,Alwan W,et al.C-reaction protein and outcome after ischemic stroke[J].Stroke,1999,30(5):981-985.
  • 6Chan Carusone S,Smieja M,Molloy W,et al.Lack of association between vascular dementia and Chlamydia pneumoniae infection:a case-control study[J].BMC Neurol,2004,4(1):15.
  • 7Devaraj S,Xu DY,Jialal I.C-reactive protein increases plasminogen activator inhibitor-lexpression and activity inhuman aortic endothelialcells:implications for the metabolic syndrome and atherothrombosis[J].Circulation,2003,107(3):398-404.
  • 8游咏,杨期东,成志,许宏伟,夏鹏飞.脑卒中患者脂蛋白(a)水平及其相关性[J].中国动脉硬化杂志,2003,11(2):163-164. 被引量:17
  • 9Sechi LA,De Marchi S.Relationship of lipoprotein(a)to variables of coagulation in hypertensive subjects[J].Invest Med,2001,49(1):12-20.

二级参考文献6

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 2Sechi LA, De Marchi S. Relationship of Lp(a) to variables of coagulation in hypertensive subjects. J Invest Med, 2001, 49 (1) : 12-22.
  • 3Scann AM, Nakajima K, Edelstein C. Apolipoprotein (a):structure and biology. Front Biosci, 2001, 6:D546-554.
  • 4Zhao SP, Xu DY. Oxidized Lp (a) enhanced the expression of P-semection in cultured human umbilical cells. Thromb Res, 2000, 100 (6) : 501-510.
  • 5Woo J, Lan E, Lam CW, Kay R, Teoh R, Wong HY, et al. Hypertension, lipoprotein(a), and apolipoproteinA-I as risk factors for storke in the Chinese.Stroke, 1991, 22 (10): 1 329-330.
  • 6林春榕,洪嘉玲,汪炳华,吴学东,狄勇.天然及氧化型脂蛋白(a)与巨噬细胞表面结合[J].中国动脉硬化杂志,2002,10(1):30-33. 被引量:14

共引文献121

同被引文献14

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部